317 related articles for article (PubMed ID: 17431029)
21. Structural elucidation of human oxidative metabolites of muraglitazar: use of microbial bioreactors in the biosynthesis of metabolite standards.
Zhang D; Zhang H; Aranibar N; Hanson R; Huang Y; Cheng PT; Wu S; Bonacorsi S; Zhu M; Swaminathan A; Humphreys WG
Drug Metab Dispos; 2006 Feb; 34(2):267-80. PubMed ID: 16280454
[TBL] [Abstract][Full Text] [Related]
22. Disposition and biotransformation of the antipsychotic agent olanzapine in humans.
Kassahun K; Mattiuz E; Nyhart E; Obermeyer B; Gillespie T; Murphy A; Goodwin RM; Tupper D; Callaghan JT; Lemberger L
Drug Metab Dispos; 1997 Jan; 25(1):81-93. PubMed ID: 9010634
[TBL] [Abstract][Full Text] [Related]
23. Metabolism and excretion of the novel antipsychotic drug ziprasidone in rats after oral administration of a mixture of 14C- and 3H-labeled ziprasidone.
Prakash C; Kamel A; Anderson W; Howard H
Drug Metab Dispos; 1997 Feb; 25(2):206-18. PubMed ID: 9029052
[TBL] [Abstract][Full Text] [Related]
24. Disposition of zatosetron, a serotonin (5-HT3) receptor antagonist, in humans.
Franz PM; Mattiuz EL; Hatcher BL; DeSante KA; Breau AP; Occolowitz JL; Dorman DE; Schmid CR; Goldberg MJ; Rubin A
Drug Metab Dispos; 1993; 21(2):249-54. PubMed ID: 8097693
[TBL] [Abstract][Full Text] [Related]
25. Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study.
Tiseo PJ; Perdomo CA; Friedhoff LT
Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):19-24. PubMed ID: 9839761
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
27. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
28. Cytochrome P450-catalyzed metabolism of ezlopitant alkene (CJ-12,458), a pharmacologically active metabolite of ezlopitant: enzyme kinetics and mechanism of an alkene hydration reaction.
Obach RS
Drug Metab Dispos; 2001 Jul; 29(7):1057-67. PubMed ID: 11408374
[TBL] [Abstract][Full Text] [Related]
29. Disposition and metabolism of [14C]SB-649868, an orexin 1 and 2 receptor antagonist, in humans.
Renzulli C; Nash M; Wright M; Thomas S; Zamuner S; Pellegatti M; Bettica P; Boyle G
Drug Metab Dispos; 2011 Feb; 39(2):215-27. PubMed ID: 21045199
[TBL] [Abstract][Full Text] [Related]
30. Metabolism and excretion of CP-122,721, a non-peptide antagonist of the neurokinin NK1 receptor, in dogs: identification of the novel cleaved product 5-trifluoromethoxy salicylic acid in plasma.
Kamel A; Du Y; Colizza K; Prakash C
Xenobiotica; 2007 May; 37(5):559-78. PubMed ID: 17523057
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacokinetics of azasetron (Serotone), a selective 5-HT3 receptor antagonist].
Tsukagoshi S
Gan To Kagaku Ryoho; 1999 Jun; 26(7):1001-8. PubMed ID: 10396331
[TBL] [Abstract][Full Text] [Related]
32. Assay of ezlopitant, a substance P receptor antagonist, and metabolites in biological matrices by gas chromatography with mass spectrometric detection: simultaneous analysis of a benzyl alcohol and alkene.
Reed-Hagen AE; Janiszewski JS; Cole RO; Obach RS
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):333-43. PubMed ID: 10993522
[TBL] [Abstract][Full Text] [Related]
33. Regiospecific and stereospecific triangulation of the structures of metabolites formed by sequential metabolism at multiple prochiral centers.
Greene RJ; Davis JA; Subramanian R; Deane MR; Emery MG; Slatter JG
Drug Metab Dispos; 2012 May; 40(5):928-42. PubMed ID: 22328582
[TBL] [Abstract][Full Text] [Related]
34. KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects.
Huskey SE; Zhu CQ; Fredenhagen A; Kühnöl J; Luneau A; Jian Z; Yang Z; Miao Z; Yang F; Jain JP; Sunkara G; Mangold JB; Stein DS
Drug Metab Dispos; 2016 May; 44(5):672-82. PubMed ID: 26921387
[TBL] [Abstract][Full Text] [Related]
35. Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans.
Vermeir M; Naessens I; Remmerie B; Mannens G; Hendrickx J; Sterkens P; Talluri K; Boom S; Eerdekens M; van Osselaer N; Cleton A
Drug Metab Dispos; 2008 Apr; 36(4):769-79. PubMed ID: 18227146
[TBL] [Abstract][Full Text] [Related]
36. Biotransformation of irbesartan in man.
Chando TJ; Everett DW; Kahle AD; Starrett AM; Vachharajani N; Shyu WC; Kripalani KJ; Barbhaiya RH
Drug Metab Dispos; 1998 May; 26(5):408-17. PubMed ID: 9571222
[TBL] [Abstract][Full Text] [Related]
37. The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.
Mannens GS; Hendrickx J; Janssen CG; Chien S; Van Hoof B; Verhaeghe T; Kao M; Kelley MF; Goris I; Bockx M; Verreet B; Bialer M; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):554-65. PubMed ID: 16936066
[TBL] [Abstract][Full Text] [Related]
38. Absorption, distribution, metabolism, and excretion (ADME) of ¹⁴C-sonidegib (LDE225) in healthy volunteers.
Zollinger M; Lozac'h F; Hurh E; Emotte C; Bauly H; Swart P
Cancer Chemother Pharmacol; 2014 Jul; 74(1):63-75. PubMed ID: 24817600
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.
Mamidi RN; Mannens G; Annaert P; Hendrickx J; Goris I; Bockx M; Janssen CG; Kao M; Kelley MF; Meuldermans W
Drug Metab Dispos; 2007 Apr; 35(4):566-75. PubMed ID: 17220243
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of cytochrome P4503A4- and 2D6-catalyzed dehydrogenation of ezlopitant as probed with isotope effects using five deuterated analogs.
Obach RS
Drug Metab Dispos; 2001 Dec; 29(12):1599-607. PubMed ID: 11717179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
